Screener
Aquestive Therapeutics, Inc. AQST Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
FAQ
- What is Aquestive Therapeutics, Inc.'s operating lease liabilities (current)?
- Aquestive Therapeutics, Inc. (AQST) reported operating lease liabilities (current) of $820K in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Aquestive Therapeutics, Inc.'s operating lease liabilities (current) increased by 43.9% year-over-year, from $570K to $820K.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s operating lease liabilities (current) has grown at a -2.8% compound annual growth rate (CAGR), from $728K to $631K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Aquestive Therapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude